These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013. Fawley WN, Davies KA, Morris T, Parnell P, Howe R, Wilcox MH, Clostridium difficile Ribotyping Network (CDRN) Working Group. Euro Surveill; 2016 Jul 21; 21(29):. PubMed ID: 27487436 [Abstract] [Full Text] [Related]
3. A prospective study of community-associated Clostridium difficile infection in Kuwait: Epidemiology and ribotypes. Jamal W, Pauline E, Rotimi V. Anaerobe; 2015 Oct 21; 35(Pt B):28-32. PubMed ID: 26144314 [Abstract] [Full Text] [Related]
4. Clinical and molecular characteristics of community-acquired Clostridium difficile infections in comparison with those of hospital-acquired C. difficile. Kwon SS, Gim JL, Kim MS, Kim H, Choi JY, Yong D, Lee K. Anaerobe; 2017 Dec 21; 48():42-46. PubMed ID: 28655581 [Abstract] [Full Text] [Related]
5. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection. Suárez-Bode L, Barrón R, Pérez JL, Mena A. Anaerobe; 2019 Feb 21; 55():124-129. PubMed ID: 30550807 [Abstract] [Full Text] [Related]
9. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study. Drabek J, Nyc O, Krutova M, Stovicek J, Matejkova J, Keil R. Ann Clin Microbiol Antimicrob; 2015 Dec 23; 14():55. PubMed ID: 26698842 [Abstract] [Full Text] [Related]
12. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Pituch H, Obuch-Woszczatyński P, Lachowicz D, Wultańska D, Karpiński P, Młynarczyk G, van Dorp SM, Kuijper EJ, Polish Clostridium difficile Study Group. Euro Surveill; 2015 Dec 23; 20(38):. PubMed ID: 26536049 [Abstract] [Full Text] [Related]
14. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Kim J, Kang JO, Kim H, Seo MR, Choi TY, Pai H, Kuijper EJ, Sanders I, Fawley W. Clin Microbiol Infect; 2013 Jun 23; 19(6):521-7. PubMed ID: 22712697 [Abstract] [Full Text] [Related]
15. First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital. Novak A, Spigaglia P, Barbanti F, Goic-Barisic I, Tonkic M. Anaerobe; 2014 Dec 23; 30():18-23. PubMed ID: 25079669 [Abstract] [Full Text] [Related]
16. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities. Furuya-Kanamori L, Riley TV, Paterson DL, Foster NF, Huber CA, Hong S, Harris-Brown T, Robson J, Clements AC. J Clin Microbiol; 2017 Jan 23; 55(1):216-225. PubMed ID: 27807147 [Abstract] [Full Text] [Related]
17. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW. Clin Infect Dis; 2012 Oct 23; 55(8):1056-63. PubMed ID: 22784871 [Abstract] [Full Text] [Related]
19. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. Ofori E, Ramai D, Dhawan M, Mustafa F, Gasperino J, Reddy M. J Hosp Infect; 2018 Aug 23; 99(4):436-442. PubMed ID: 29410012 [Abstract] [Full Text] [Related]